Antibiotic Stewardship Advisory

Keeping Patients Safe, Preserving Antibiotics, Preventing Infection, Decreasing Costs, and Improving Health

Program Overview

Led by an infectious disease physician, our multidisciplinary ASP team incorporates site visits, program management, education, evidence-based clinical transformation processes, data analysis, and ongoing monitoring to promote precision prescribing. We educate physicians, pharmacists, and others to thrive in a population health environment. Our program prepares hospitals, critical access hospitals, and long-term care facilities for new Joint Commission and CMS antibiotic stewardship standards. PYA has also just released a new online tool. If a hospital inputs their annual antibiotic spend and uploads their antibiogram to our new online tool, our ASP team can provide an Antibiotic Savings Analysis.

The Problem

The Life-Threatening Advance of Antibiotic Resistance – The Post-Antibiotic Era

  • Each year, two-million people in the U.S. are infected with antibiotic-resistant organisms
  • Antibiotic-resistant infections result in more than 23,000 deaths annually
  • By 2050, more people will die from antibiotic-resistant infections than cancer according to Review on Antimicrobial Resistance

Over-Prescribing Antibiotics: Expensive, Ineffective, and Adversely Impacts Patient Care

  • Antibiotic-resistant infections cause 8 million additional days in the hospital, costing an estimated $55-70 billion in direct healthcare and productivity loss
  • Improperly prescribed antibiotics have no clinical benefit and place patients at greater risk of adverse effects
  • The CDC reports…
    • Hospitals – 33% of antibiotics are prescribed unnecessarily
    • Nursing Homes – 40-75% of antibiotics maybe unnecessary or inappropriate

The Pipeline for New Antibiotics Is Insufficient

No new antibiotic types have been developed in more than 30 years

The HAC Reduction Program Adds Clostridium difficile and MRSA in 2017

HAC Reduction Program penalties can be severe. A mid-sized hospital performing in the bottom 25% may incur penalties of $1 million or morecdiff


New Standards for ASPs

New Joint Commission Antimicrobial Stewardship Standard

  • Applicable to hospitals, critical access hospitals, and nursing care centers
  • Effective January 1, 2017
  • Required – Multidisciplinary team must include infectious disease specialist
  • Required – Staff and patient education regarding the appropriate use of antimicrobial medications

CMS Requirement

  • ASPs will be tied to Conditions of Participation – Will mandate an ASP or risk losing CMS reimbursement
  • Hospitals are required to have a formal procedure for all practitioners to review the appropriateness of any antibiotics prescribed

ASP Goals

An effective ASP promotes precision prescribing:

  • Total antibiotic inventory and spending reduced by 10-40%
  • Reduces Clostridium difficile incidence and expense
  • Improves HAC scores and mitigates reimbursement penalties
  • Leads to decreased litigation risk
  • Improves patient safety and quality of care
  • Preserves, and over time, improves the effectiveness of first-line antibiotics
  • Improves Hospital Compare rankings
  • Provides a foundation for public awareness campaigns
  • Contributes to achievement of Triple Aim objectives

Why PYA?

ASP EXPERTISE – PYA’s team has more than 20 years’ experience integrating and overseeing ASPs
MULTIDISCIPLINARY ASP TEAM – Infectious disease physician leader, nurses, project managers, data analysts, financial analysts, and administrators
ELASTIC IN DESIGN – ASPs designed around organization needs, personnel, and particular conditions
CAPACITY – With clients in all 50 states, PYA consistently ranks in Modern Healthcare’s top 20 largest healthcare consulting firms in U.S.
Our professionals are experienced in value-based reimbursement, population health, CMS regulations, ICD-10 coding, integration, patient safety and patient safety organizations, electronic medical records, accountable care organizations, clinically integrated networks, CAHs, skilled nursing and long-term care
facilities, transitions of care, evidence-based medicine, compliance, and more.

Our ASP Results

Antibiotic Stewardship Advisory
Insights that may also interest you

White Papers





Our Team

  • Edward Pershing

    Edward Pershing

    Chief Executive Officer

  • Michael Levesque

    Michael Levesque

    Senior Director of Business Strategy

  • James M. Keegan, MD

    James M. Keegan, MD



PYA Population Health Ascend

PYA Healthcare Blog

PYA Thought Leadership Services

The Healthcare Loop